Vedolizumab Biosimilar – Anti-ITGA4_ITGB7 mAb – Research Grade

Reference:
Size

,

Isotype

IgG1, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameVedolizumab Biosimilar - Anti-ITGA4_ITGB7 mAb - Research Grade
SourceCAS 943609-66-3
SpeciesHumanized
Expression systemMammalian cells
Molecular weight147kDa
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsVedolizumab,LDP-02,LDP02,MLN-02,MLN0002,MLN02,ITGA4_ITGB7,anti-ITGA4_ITGB7
ReferencePX-TA1212
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Vedolizumab Biosimilar - Anti-ITGA4_ITGB7 mAb - Research Grade

General information on Anti-ITGA4_ITGB7(Homo sapiens) (Vedolizumab) Monoclonal Antibody

Vedolizumab is a recombinant humanized monoclonal antibody of isotype IgG1 raised against human lymphocyte alpha 4 beta 7 integrin, a key mediator of gastrointestinal inflammation. It is used for the treatment of active ulcerative colitis and Crohn’s disease. Vedolizumab can reduce intestinal inflammation by blocking its main target alpha 4 beta 7 integrin.

SDS-PAGE for Vedolizumab Biosimilar - Anti-ITGA4_ITGB7 mAb

Vedolizumab Biosimilar - Anti-ITGA4_ITGB7 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Vedolizumab Biosimilar – Anti-ITGA4_ITGB7 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

ITGA4 recombinant protein
Antigen

ITGA4 recombinant protein

PX-P5178 420€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products